Andere Sprachen SOCL CAPI

Aktien

A3CTVD

KYG8253W1096

DNAC

Realtime-Estimate Cboe BZX Andere Börsenplätze 21:33:15 03.05.2024			% 5 Tage	% 1. Jan.
2,185 ^USD	+1,63 %		-20,66 %	-78,06 %

2022	Social Capital Suvretta Holdings Corp. III meldet Ergebnis für das zweite Quartal und die sechs Monate bis zum 30. Juni 2022	CI
2022	ProKidney schließt SPAC-Fusion mit Social Capital Suvretta Holdings ab; Aktien werden an der Nasdaq gehandelt	MT

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Social Capital Suvretta Holdings Corp. III Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	12.08.22
SOCL CAPI : Revolutionary Chronic Kidney Disease Therapeutics Company ProKidney to List on the Nasdaq Following Business Combination with Social Capital Suvretta Holdings Corp. III - Form 8-K	15.07.22
ProKidney Completes SPAC Merger With Social Capital Suvretta Holdings; Shares to Start Nasdaq Trading	12.07.22
Social Capital Suvretta III : Revolutionary Chronic Kidney Disease Therapeutics Company ProKidney to List on the Nasdaq Following Business Combination with Social Capital Suvretta Holdings Corp. III - Form 8-K	12.07.22
Revolutionary Chronic Kidney Disease Therapeutics Company ProKidney to List on the Nasdaq Following Business Combination with Social Capital Suvretta Holdings Corp. III	12.07.22
Social Capital Suvretta Holdings Corp. III(NasdaqCM:DNAC) dropped from NASDAQ Composite Index	12.07.22
Social Capital Suvretta III : Announces Reconvened Extraordinary General Meeting of Shareholders - Form 8-K	11.07.22
SOCIAL CAPITAL SUVRETTA HOLDINGS CORP. III : Submission of Matters to a Vote of Security Holders, Other Events, Financial Statements and Exhibits (form 8-K)	11.07.22
ProKidney LLC completed the acquisition of Social Capital Suvretta Holdings Corp. III from SCS Sponsor III LLC, Millennium Management LLC, Adage Capital Management, L.P. and others in a reverse merger transaction.	11.07.22
Social Capital Suvretta Holdings Corp. III Announces Reconvened Extraordinary General Meeting of Shareholders	09.07.22
SOCIAL CAPITAL SUVRETTA HOLDINGS CORP. III : Other Events (form 8-K)	06.07.22
Social Capital Suvretta III : REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM - Form 8-K/A	10.06.22
SOCIAL CAPITAL SUVRETTA HOLDINGS CORP. III Other Events, Financial Statements and Exhibits (form 8-K/A)	10.06.22
Observed Safety Profile Supports Bilateral Dosing of ProKidney’s REACT™ – 007 Update	07.06.22
ProKidney to present at upcoming investor conferences	20.05.22
SOCIAL CAPITAL SUVRETTA HOLDINGS CORP. III Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	16.05.22
Social Capital Suvretta Holdings Corp. III Reports Earnings Results for the First Quarter Ended March 31, 2022	16.05.22
SOCIAL CAPITAL SUVRETTA HOLDINGS CORP. III : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	28.04.22
SOCIAL CAPITAL SUVRETTA HOLDINGS CORP. III : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Financial Statements and Exhibits (form 8-K)	22.04.22
Social Capital Suvretta Holdings Corp. III Issues an Unsecured Promissory Note	22.04.22

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen SOCL CAPI

Aktien

A3CTVD

KYG8253W1096

DNAC

Andere Sprachen

Filter